Furthermore, our findings confirmed and extended the previous data that in addition to inhibition of CSE–induced increase in OPN expression [18, 27], simvastatin also inhibited CSE-induced increase in IL-13 production by MDM from patients with COPD in a dose-dependent manner. The gene discussed is SPP1; the disease is chronic obstructive pulmonary disease.